" class="no-js "lang="en-US"> Pascal Soriot - Medtech Alert
Tuesday, May 20, 2025
Pascal Soriot

Pascal Soriot

About Pascal Soriot

Pascal brings a passion for science and medicine as well as significant experience in established and emerging markets, strength of strategic thinking, a successful track record of managing change and executing strategy, and the ability to lead a diverse organisation. He served as Chief Operating Officer of Roche’s pharmaceuticals division from 2010 to September 2012 and, prior to that, Chief Executive Officer of Genentech, a biologics business, where he led its successful merger with Roche. Pascal joined the pharmaceutical industry in 1986 and has worked in senior management roles in numerous major companies around the world. He is a doctor of veterinary medicine (École Nationale Vétérinaire d’Alfort, Maisons-Alfort) and holds an MBA from HEC, Paris.

Related Story

AstraZeneca Unveils The Discovery Centre (DISC) in Cambridge

November 23 2021

AstraZeneca will today, in the presence of His Royal Highness The Prince of Wales, formally […]

Two Billion Doses of AstraZeneca’s COVID-19 Vaccine Supplied to Countries Across the World Less Than 12 Months After First Approval

November 16 2021

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine […]

AstraZeneca to Invest $360m in Advanced Manufacturing Facility in Ireland

September 21 2021

AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small […]